drugset / Trial / NCT07140380

Phase 2b Controlled Study

NCT07140380 ↗

Phase 2 Completed 30 enrolled IVIEW Therapeutics Inc.
RandomizedCrossoverSingle-blindTreatment

Summary

Double-masked two period controlled trial of three eyelid wipe dosing techniques

Timeline

Start
2025-08-20
Primary completion
2025-10-08
Completion
2025-10-08

Drugs

EvaluationDrugModalityDoseRoute
Subject IVW-1001 Unknown 0.2 % Topical
Subject IVW-1001 Unknown 0.4 % Topical

Indications